Centiva Capital, LP Vertex Pharmaceuticals Inc Transaction History

Centiva Capital, LP

$4.79 Billion
Q3 2024

A detailed history of Centiva Capital, LP transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Centiva Capital, LP holds 1,000 shares of VRTX stock, worth $408,180. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,000

Previous 1,000 -0.0%

Holding current value

$408,180

Previous $468,000 0.64%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $63,480 - $69,797	138 Added 4.78%	3,025 $1.41 Million
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $227,436 - $281,121	579 Added 25.09%	2,887 $1.35 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $535,704 - $586,149	1,314 Added 132.19%	2,308 $964,000
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $166,012 - $198,769	484 Added 94.9%	994 $404,000
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $3.37 Million - $3.61 Million	-9,952 Reduced 95.13%	510 $177,000
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $3.06 Million - $3.42 Million	9,723 Added 1315.7%	10,462 $3.68 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $88,934 - $101,453	314 Added 73.88%	739 $232,000
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $15,716 - $17,681	-55 Reduced 11.46%	425 $122,000
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $131,438 - $146,654	480 New	480 $139,000
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $5.29 Million - $6.58 Million	22,500 New	22,500 $6.34 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $2 Million - $2.24 Million	-11,053 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $1.08 Million - $1.27 Million	5,757 Added 108.7%	11,053 $2.23 Million
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $334,337 - $389,715	1,615 Added 43.87%	5,296 $1.14 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $210,322 - $280,507	1,016 Added 38.12%	3,681 $870,000
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $556,294 - $659,545	-2,176 Reduced 44.95%	2,665 $725,000
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $117,024 - $153,520	519 Added 12.01%	4,841 $1.41 Million
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $1.71 Million - $2.12 Million	-8,552 Reduced 66.43%	4,322 $1.03 Million
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $138,369 - $185,845	-830 Reduced 6.06%	12,874 $2.82 Million
Q3 2019 Nov 13, 2019	BUY	$166.23 - $187.09 $2.08 Million - $2.34 Million	12,496 Added 1034.44%	13,704 $2.32 Million
Q2 2019 Aug 13, 2019	SELL	$164.61 - $190.37 $374,816 - $433,472	-2,277 Reduced 65.34%	1,208 $221,000
Q1 2019 May 14, 2019	BUY	$163.73 - $194.7 $570,599 - $678,529	3,485 New	3,485 $641,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Account

Centiva Capital, LP Vertex Pharmaceuticals Inc Transaction History